Altogether, these results suggest that FKBP4 may be a useful biological marker to estimate breast cancer progression and prognosis, and may functionally play a role in promoting breast cancer growth in ER-positive and more interestingly in ER/PR-negative tumors. Here, FKBP4 is linked to breast carcinoma.